Pathmanandavel S, Crumbaker M, Yam AO, Nguyen A, et al. (177)Lutetium PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castrate-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial. J Nucl Med 2021 Jul 29. pii: jnumed.121.262552. doi: 10.2967/jnumed.121.262552.
PMID: 34326127